ConductScience.org, home

Paper38517618

Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.

BharathwajChetty B and 6 others. Cancer Metastasis Rev, 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics. Papers, record 38517618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38517618

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
PubMed
Journal
Cancer Metastasis Rev
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
1.78, provisional
iCite
Revised in PubMed
2026-07-14
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1BharathwajChetty BBandari
2Sajeev AAnjana
3Vishwa RRavichandran
4Aswani BSBabu Santha
5Alqahtani MSMohammed S
6Abbas MMohamed
7Kunnumakkara ABAjaikumar B

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell PlasticityMajor topic
NeoplasmsMajor topic
Humans
Signal Transduction
Epithelial-Mesenchymal Transition
Drug Resistance, Neoplasm
Receptors, Cytoplasmic and Nuclear
Neoplastic Stem Cells

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R.G.P.2/555/44Deanship of Scientific Research at King Khalid University (KKU)PubMed
BT/556/NE/U-Excel/2016Department of Biotechnology (DBT), Government of IndiaPubMed

Source PubMed

Download CSV of grants

References280

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
233538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
335022204Hallmarks of Cancer: New Dimensions.Cancer Discov2022https://conductscience.org/library/papers/35022204PubMed
410647931The hallmarks of cancer.Cell2000https://conductscience.org/library/papers/10647931PubMed
530992279Cellular Plasticity in Cancer.Cancer Discov2019https://conductscience.org/library/papers/30992279PubMed
619006453Stem cells and the phenomena of plasticity and diversity: a limiting property of carcinogenesis.Stem Cells Dev2008https://conductscience.org/library/papers/19006453PubMed
718485877The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell2008https://conductscience.org/library/papers/18485877PubMed
830594349EMT Transition States during Tumor Progression and Metastasis.Trends Cell Biol2019https://conductscience.org/library/papers/30594349PubMed
929071215The Different Mechanisms of Cancer Drug Resistance: A Brief Review.Adv Pharm Bull2017https://conductscience.org/library/papers/29071215PubMed
1026537958Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.Recent Pat Anticancer Drug Discov2016https://conductscience.org/library/papers/26537958PubMed
1130961357Cancer drug development: The missing links.Exp Biol Med (Maywood)2019https://conductscience.org/library/papers/30961357PubMed
1215641020Molecular mechanisms of drug resistance.J Pathol2005https://conductscience.org/library/papers/15641020PubMed
138521507The nuclear receptor superfamily: the second decade.Cell1995https://conductscience.org/library/papers/8521507PubMed
1428553937Stem cell plasticity enables hair regeneration following Lgr5+ cell loss.Nat Cell Biol2017https://conductscience.org/library/papers/28553937PubMed
1529479084Stretching the limits: from homeostasis to stem cell plasticity in wound healing and cancer.Nat Rev Genet2018https://conductscience.org/library/papers/29479084PubMed
1637789138Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling.Cancer Metastasis Rev2024https://conductscience.org/library/papers/37789138PubMed
1732595946Cell plasticity in cancer cell populations.F1000Res2020https://conductscience.org/library/papers/32595946PubMed
1830554963Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.Cell Stem Cell2019https://conductscience.org/library/papers/30554963PubMed
1937853437Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.Mol Cancer2023https://conductscience.org/library/papers/37853437PubMed
2011689955Stem cells, cancer, and cancer stem cells.Nature2001https://conductscience.org/library/papers/11689955PubMed

See all 280 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42421656Ecdysone receptor autonomously controls germ cell differentiation in the Drosophila ovary.Development2026https://conductscience.org/library/papers/42421656PubMed
41497585Ecdysone Receptor autonomously controls germ cell differentiation in the Drosophila ovary.bioRxiv2025https://conductscience.org/library/papers/41497585PubMed
41462674The Redox-Adhesion-Exosome (RAX) Hub in Cancer: Lipid Peroxidation-Driven EMT Plasticity and Ferroptosis Defense with HNE/MDA Signaling and Lipidomic Perspectives.Antioxidants (Basel)2025https://conductscience.org/library/papers/41462674PubMed
40806474Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications.Int J Mol Sci2025https://conductscience.org/library/papers/40806474PubMed
39327610Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.Mil Med Res2024https://conductscience.org/library/papers/39327610PubMed
39077471Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.Front Oncol2024https://conductscience.org/library/papers/39077471PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38517618

GET https://conductscience.org/api/papers/v1/38517618/references?page=2